Literature DB >> 25986290

Prevalence and predictors of potentially inappropriate medications among home care elderly patients in Qatar.

Eman Alhmoud1, Sabah Khalifa2, Asma Abdulaziz Bahi3.   

Abstract

BACKGROUND: Older patients receiving home health care are particularly at risk of receiving potentially inappropriate medications compared to community-dwelling population. Data on appropriateness of prescribing in these patients is limited.
OBJECTIVE: To investigate the prevalence, patterns and determinants of potentially inappropriate medications among elderly patients receiving Home Health Care Services in Qatar.
SETTING: Home Health Care Services department in Hamad Medical Corporation-Qatar.
METHODS: A cross-sectional study, conducted over a 3 months period. Patients 65 years and older, taking at least one medication and receiving home care services were included. Potentially inappropriate medications were identified and classified in accordance with the American Geriatrics Society 2012 Beers Criteria. MAIN OUTCOME MEASURE: Prevalence of potentially inappropriate medications using updated Beers criteria.
RESULTS: A total of 191 patients (38.2%) had at least one potentially inappropriate medication. As per Beers criteria, 35% of medications were classified as medications to be avoided in older adults regardless of conditions and 9% as potentially inappropriate medications when used with certain diseases or syndromes. The majority of potentially inappropriate medications (56%) were classified as medications to be used with caution. The two leading classes of potentially inappropriate medications were antipsychotics (27.4%) and selective serotonin reuptake inhibitors (16%). Significant predictors of inappropriate prescribing were hypertension [adjusted OR 1.7; 95% CI (1.0, 2.8)], dementia [adjusted OR 2.0; 95% CI (1.2, 3.1)], depression [adjusted OR 21.6; 95% CI (2.8, 168.4)], and taking more than ten prescribed medications [adjusted OR 1.9; 95% CI (1.3, 2.8)].
CONCLUSION: Prescribing potentially inappropriate medications is common among older adults receiving home health care services in Qatar, a finding that warrants further attention. Polypharmacy, hypertension, depression and dementia were significantly associated with potentially inappropriate prescribing.

Entities:  

Keywords:  Beers criteria; Home care patients; Potentially inappropriate medications (PIM); Qatar

Mesh:

Year:  2015        PMID: 25986290     DOI: 10.1007/s11096-015-0125-0

Source DB:  PubMed          Journal:  Int J Clin Pharm


  40 in total

1.  Adverse Drug Reactions in Elderly People: The challenge of safer prescribing.

Authors:  Anne Spinewine
Journal:  BMJ       Date:  2008-04-08

2.  Potentially inappropriate medications defined by STOPP criteria and the risk of adverse drug events in older hospitalized patients.

Authors:  Hilary Hamilton; Paul Gallagher; Cristin Ryan; Stephen Byrne; Denis O'Mahony
Journal:  Arch Intern Med       Date:  2011-06-13

3.  Efficacy and adverse effects of atypical antipsychotics for dementia: meta-analysis of randomized, placebo-controlled trials.

Authors:  Lon S Schneider; Karen Dagerman; Philip S Insel
Journal:  Am J Geriatr Psychiatry       Date:  2006-03       Impact factor: 4.105

4.  Use of the Beers criteria to predict adverse drug reactions among first-visit elderly outpatients.

Authors:  Chia-Ming Chang; Pheng-Ying Yeh Liu; Yea-Huei Kao Yang; Yi-Ching Yang; Chun-Feng Wu; Feng-Hwa Lu
Journal:  Pharmacotherapy       Date:  2005-06       Impact factor: 4.705

5.  Risk of death with atypical antipsychotic drug treatment for dementia: meta-analysis of randomized placebo-controlled trials.

Authors:  Lon S Schneider; Karen S Dagerman; Philip Insel
Journal:  JAMA       Date:  2005-10-19       Impact factor: 56.272

6.  STOPP (Screening Tool of Older Persons' potentially inappropriate Prescriptions): application to acutely ill elderly patients and comparison with Beers' criteria.

Authors:  Paul Gallagher; Denis O'Mahony
Journal:  Age Ageing       Date:  2008-10-01       Impact factor: 10.668

7.  Inappropriate medication use as a risk factor for self-reported adverse drug effects in older adults.

Authors:  Elizabeth A Chrischilles; Rachel VanGilder; Kara Wright; Michael Kelly; Robert B Wallace
Journal:  J Am Geriatr Soc       Date:  2009-06       Impact factor: 5.562

Review 8.  Use of antipsychotics in elderly patients with dementia: do atypical and conventional agents have a similar safety profile?

Authors:  Gianluca Trifirò; Edoardo Spina; Giovanni Gambassi
Journal:  Pharmacol Res       Date:  2008-10-08       Impact factor: 7.658

9.  2012 American Geriatrics Society Beers criteria: enhanced applicability for detecting potentially inappropriate medications in European older adults? A comparison with the Screening Tool of Older Person's Potentially Inappropriate Prescriptions.

Authors:  Encarnación Blanco-Reina; Gabriel Ariza-Zafra; Ricardo Ocaña-Riola; Matilde León-Ortiz
Journal:  J Am Geriatr Soc       Date:  2014-06-10       Impact factor: 5.562

10.  Antipsychotic drug use and mortality in older adults with dementia.

Authors:  Sudeep S Gill; Susan E Bronskill; Sharon-Lise T Normand; Geoffrey M Anderson; Kathy Sykora; Kelvin Lam; Chaim M Bell; Philip E Lee; Hadas D Fischer; Nathan Herrmann; Jerry H Gurwitz; Paula A Rochon
Journal:  Ann Intern Med       Date:  2007-06-05       Impact factor: 25.391

View more
  17 in total

Review 1.  The scope of drug-related problems in the home care setting.

Authors:  Carla Meyer-Massetti; Christoph R Meier; B Joseph Guglielmo
Journal:  Int J Clin Pharm       Date:  2018-01-11

2.  Prevalence and Predictors of Potentially Inappropriate Medications Among Patients Aged ≥65 Years on Hospital Admissions in Kuwait.

Authors:  Hesah Alshammari; Eman Al-Saeed; Zamzam Ahmed; Zoe Aslanpour
Journal:  Clin Interv Aging       Date:  2022-07-06       Impact factor: 3.829

Review 3.  The patterns and implications of potentially suboptimal medicine regimens among older adults: a narrative review.

Authors:  Georgie B Lee; Christopher Etherton-Beer; Sarah M Hosking; Julie A Pasco; Amy T Page
Journal:  Ther Adv Drug Saf       Date:  2022-07-04

4.  Potentially Inappropriate Medication and Polypharmacy in Nursing Home Residents: A Cross-Sectional Study.

Authors:  Raquel Díez; Raquel Cadenas; Julen Susperregui; Ana M Sahagún; Nélida Fernández; Juan J García; Matilde Sierra; Cristina López
Journal:  J Clin Med       Date:  2022-06-30       Impact factor: 4.964

5.  Potentially Inappropriate Medications in the Elderly in Korean Long-Term Care Facilities.

Authors:  Hee-Jin Hwang; Sang-Hwan Kim; Kang Soo Lee
Journal:  Drugs Real World Outcomes       Date:  2015-12-01

6.  An evaluation of the prevalence of potentially inappropriate medications in older people with cognitive impairment living in Northern Sweden using the EU(7)-PIM list.

Authors:  Eva Sönnerstam; Maria Sjölander; Maria Gustafsson
Journal:  Eur J Clin Pharmacol       Date:  2017-03-01       Impact factor: 2.953

7.  The Association between Polypharmacy and Dementia: A Nested Case-Control Study Based on a 12-Year Longitudinal Cohort Database in South Korea.

Authors:  Hae-Young Park; Ji-Won Park; Hong Ji Song; Hyun Soon Sohn; Jin-Won Kwon
Journal:  PLoS One       Date:  2017-01-05       Impact factor: 3.240

8.  Polypharmacy leads to increased prevalence of potentially inappropriate medication in the Indonesian geriatric population visiting primary care facilities.

Authors:  Rizky Abdulah; Widya N Insani; Dika P Destiani; Nurul Rohmaniasari; Nithya D Mohenathas; Melisa I Barliana
Journal:  Ther Clin Risk Manag       Date:  2018-09-04       Impact factor: 2.423

9.  Potentially inappropriate medication use among geriatric patients in primary care setting: A cross-sectional study using the Beers, STOPP, FORTA and MAI criteria.

Authors:  Abdelmoneim Awad; Olivia Hanna
Journal:  PLoS One       Date:  2019-06-13       Impact factor: 3.240

10.  Potentially Harmful Medication Use and Decline in Health-Related Quality of Life among Community-Dwelling Older Adults.

Authors:  Kenya Ie; Eric Chou; Richard D Boyce; Steven M Albert
Journal:  Drugs Real World Outcomes       Date:  2017-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.